Back to Search Start Over

NAPLEX Preparatory Perceptions from Recent Graduates at One College of Pharmacy.

Authors :
Chilbert MR
Albanese N
Cieri-Hutcherson N
O'Brocta R
Woodruff AE
Maerten-Rivera J
Source :
American journal of pharmaceutical education [Am J Pharm Educ] 2024 Feb; Vol. 88 (2), pp. 100642. Date of Electronic Publication: 2024 Jan 05.
Publication Year :
2024

Abstract

Objectives: The current study assessed how students prepared for the North American Pharmacist Licensure Examination (NAPLEX), and examined factors associated with first-time pass rates. In addition, updated information on student perceptions of several currently available NAPLEX preparation resources was collected.<br />Methods: A survey was administered to 2022 graduates from 1 school, which collected data on student demographics, and NAPLEX-related items regarding when the exam was taken and how students prepared, including resources used. The association between first-time success (pass, no pass) and grade point average (GPA), timing of test date after graduation, effort toward exam, and number of hours studied was examined. In addition, student ratings of NAPLEX preparation resources in terms of usefulness, representativeness to actual examination, and monetary value were reported.<br />Results: A total of 52 individuals completed the survey. Pharmacy GPA over 3.5, taking the NAPLEX within 60 days of graduation, and exerting moderate to extensive effort to pass the NAPLEX were all associated with higher first-time pass rates. All students reported using at least 1 RxPrep resource, which students rated highly and suggested the school provide as a resource for NAPLEX preparation.<br />Conclusion: This study found that taking the NAPLEX examination within 60 days of graduation, contributing moderate to extensive effort to pass the examination, as well as a cumulative GPA of 3.5 (out of 4) or above were related to success on the NAPLEX. Additionally, students reported high satisfaction with RxPrep resources.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 American Association of Colleges of Pharmacy. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1553-6467
Volume :
88
Issue :
2
Database :
MEDLINE
Journal :
American journal of pharmaceutical education
Publication Type :
Academic Journal
Accession number :
38185466
Full Text :
https://doi.org/10.1016/j.ajpe.2024.100642